NEW YORK (GenomeWeb News) – Roche today said that Molecular Diagnostic sales rose 4 percent year over year at constant exchange rates, while Diagnostic Division revenues were up also 4 percent in the second quarter.

Molecular Diagnostics increased to to CHF411 million ($439.9 million) from CHF395 million as Diagnostic Division revenues increased to CHF2.71 billion from CHF2.61 billion

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.